2024-09-01 - Analysis Report
## JNJ Stock Analysis

**Company Overview:** Johnson & Johnson (JNJ) is a multinational pharmaceutical, medical devices, and consumer packaged goods company. 

**1. Performance Comparison:**

* **Cumulative Return:** JNJ (19.88%) significantly underperformed the S&P 500 (VOO) (89.66%). The difference in cumulative return is -48.3%.
* **Relative Performance:** The relative performance of JNJ against the S&P 500 is currently at 14.45%. This means JNJ's performance is currently in the 14.45th percentile relative to its historical performance against the S&P 500. 

**2. Recent Price Movements:**

* **Closing Price:** $165.86
* **5-Day Moving Average:** $164.31
* **20-Day Moving Average:** $161.22
* **60-Day Moving Average:** $154.17

JNJ's price is currently trading above all its moving averages, indicating a short-term bullish trend.

**3. Technical Indicators:**

* **RSI:** 74.35 -  The RSI is above 70, indicating the stock is currently in overbought territory.
* **PPO:** 0.09 -  The PPO is positive, suggesting a bullish trend.
* **Delta_Previous_Relative_Divergence:** -2.73 - This indicates a recent decrease in relative performance.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-25 | 1.95 | 22.45 B$ |
| 2024-05-01 | 1.35 | 21.38 B$ |
| 2024-02-16 | 1.68 | 21.39 B$ |
| 2023-10-27 | 10.32 | 21.35 B$ |
| 2024-02-16 | 10.32 | 21.35 B$ |

JNJ's recent earnings show a mixed performance, with some quarters exceeding expectations while others fell short. The company is facing challenges in its pharmaceutical business, particularly in the consumer health sector. However, the company has a strong presence in the medical device and diagnostics market.

**5. Overall Analysis:**

JNJ is currently in an overbought territory and its performance has been lagging behind the S&P 500. While the stock is trading above its moving averages, suggesting a short-term bullish trend, the recent decrease in relative performance and mixed earnings are concerns. Investors should carefully consider these factors before making any investment decisions.  

**6.  Potential Investment Strategies:**

* **Short-term:** Investors with a short-term outlook might consider taking profit as the stock is currently overbought and its relative performance is declining.
* **Long-term:** Long-term investors might consider holding JNJ as the company has a strong track record and a diversified business portfolio. However, they should closely monitor the company's progress in its pharmaceutical business and its future prospects. 

**Disclaimer:** This analysis is for informational purposes only and should not be considered investment advice. Please consult with a financial professional before making any investment decisions.
